Calavo Growers (CVGW) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
13 Jun, 2025Executive summary
Net sales from continuing operations rose 16.5% year-over-year to $184.4 million for Q2 2024, driven by strong avocado and tomato performance in the Grown segment.
Gross profit increased 30% to $20.4 million, with consolidated gross margin improving to 11.0% from 9.9% a year ago.
Net income from continuing operations was $6.5 million, up from $1.4 million in Q2 2023; adjusted net income reached $8.9 million.
The company is in non-binding negotiations to sell its Fresh Cut business, now classified as discontinued operations, targeting completion in Q3 2024.
Ongoing internal investigation into potential FCPA issues in Mexico, with $2.7 million in professional fees incurred in Q2 2024.
Financial highlights
Grown segment net sales increased 19% to $166.8 million, while Prepared segment net sales decreased 2% to $17.6 million for Q2 2024.
Gross profit for Grown products rose 27% to $16.0 million; Prepared products gross profit rose 40% to $4.3 million.
Adjusted EBITDA from continuing operations was $13.4 million for Q2 2024, up from $9.9 million in Q2 2023.
SG&A expenses were $13.0 million (7.1% of net sales), down from Q2 2023, despite FCPA investigation costs.
Net debt at quarter-end was $48.5 million, with $47.3 million in liquidity.
Outlook and guidance
Targeting completion of the Fresh Cut business sale in Q3 2024; proceeds expected to reduce debt and return cash to shareholders.
Costs related to the FCPA investigation are expected to decline beginning in Q3 2024.
Management expects robust performance to continue in Q3, citing strong starts and focus on core business value maximization.
Management expects sufficient liquidity from operations and credit facilities to meet future needs.
Latest events from Calavo Growers
- Shareholders to vote on a merger offering Calavo holders cash and Mission Produce stock at a premium.CVGW
Proxy filing20 Mar 2026 - Net sales fell 21%, but Prepared segment grew 20% and merger progress continued.CVGW
Q1 202612 Mar 2026 - Deal creates a top produce platform with $25M in synergies, closing by August 2026.CVGW
M&A announcement15 Jan 2026 - Net income soared 192% year-over-year; merger with Mission Produce targets $25M synergies.CVGW
Q4 202514 Jan 2026 - Annual meeting covers director elections, auditor ratification, compensation, and equity plan extension.CVGW
Proxy Filing1 Dec 2025 - Director elections, auditor ratification, and equity plan changes up for vote at annual meeting.CVGW
Proxy Filing1 Dec 2025 - Annual meeting set for April 23, 2025, with key proposals and voting details in proxy materials.CVGW
Proxy Filing1 Dec 2025 - Prepared segment growth and legal resolutions drove improved adjusted results despite FDA-related costs.CVGW
Q3 20259 Sep 2025 - Net sales up 12%, Fresh Cut sold, debt retired, and dividend doubled on strong avocado margins.CVGW
Q3 202413 Jun 2025